Skip to main content
. 2021 Nov 17;11(11):e052582. doi: 10.1136/bmjopen-2021-052582

Table 2.

Hospital data—severity of diseases and antibiotic treatment

Non-survivors, n=195 Survivors, n=195 P value
Ambulance transport (%) 158 (81) n194 136 (70) n193 0.01
Admission to hospital (%)
 Emergency department 165 (85) 178 (91) 0.04
 Specialist outpatient department 30 (15) 17 (9) 0.04
Severity of disease (SD)
 Habitual SOFA 0.8 (1.1) n185 0.4 (0.8) n193 <0.01
 SOFA score on admission 4.2 (2.3) n161 2.3 (1.7) n160 <0.01
 SOFA score at 24 hours 6.8 (3.6) n187 3.8 (2.7) n195 <0.01
 Maximum lactate level mmol/l first 24 hours 4.6 (4.0) n122 2.9 (1.9) n110 <0.01
 NEWS 2 7.1 (4.0) n163 5.0 (3.4) n181 <0.01
Sepsis (%)
 Sepsis on admission 119 (75) n158 82 (52) n158 <0.01
 Sepsis at 24 hours 176 (95) n185 152 (79) n193 <0.01
ICU care within 24 hours (%) 22 (11.3) 9 (4.6) 0.01
Antibiotic treatment
 Antibiotic administration (%) 186 (96) n193 192 (99.5) n193 0.07
 Time (hours) to antibiotics from admission median, (Q1–Q3) 2.8 (1.4–5.3) n185 3.0 (1.4–6.2) n192 0.58
 First dose antibiotic within 1 hour (%) 34 (18) n185 30 (16) n192 0.48
 Appropriate empirical antibiotic therapy (%) 162 (87) n186 185 (96) n192 <0.01
 Microbiologically appropriate empirical antibiotic therapy (%) 155 (83) n186 168 (88) n192 0.25
Intravenous fluids in the ED (%) 124 (76) n163 116 (68) n171 0.09

Data are presented as no. (%) or mean (SD).

Pearson χ2, Fisher’s exact test or t-test, as appropriate. P values <0.05 are shown in italics. Time indications are calculated with median, interquartile 25th to 75th percentile range (Q1–Q3) and Mann-Whitney. Two non-survivors with end-of-life care (EoLC) on arrival at hospital, and their controls were excluded from the analysis regarding antibiotic treatment and intravenous fluids.

ED, emergency department; ICU, intensive care unit; NEWS 2, National Early Warning Score 2; SOFA, Sequential Organ Failure Assessment.